HOME > COMMENTARY
COMMENTARY
- A Cluster of Diseases - Metabolic Syndrome:Reflecting an Aging Society -1-
October 31, 2005
- Commentary 2005 Will Be "Year 1" of Japanese Drug Industry Reorganization
October 17, 2005
- COMMENTARY 2 articles
October 10, 2005
- COMMENTARY 6 articles
September 19, 2005
- Where Will the Japanese Pharmaceutical Industry Drift? - From "The Sky Is the Limit" to the Abyss -
August 29, 2005
- COMMENTARY 5 articles
August 8, 2005
- 2 Rosai Hospitals Start Prescriptions by the Generic Name
July 25, 2005
- COMMENTARY 6 articles
July 25, 2005
- Type 2 Diabetic Mellitus: Expanding Therapeutics Strategy (3)
July 4, 2005
- Former Reviewers' Interviews Make OPIR Report Exciting
June 27, 2005
- Type 2 Diabetic Mellitus: Expanding Therapeutics Strategy (2)
June 27, 2005
- Type 2 Diabetic Mellitus: Expanding Therapeutics Strategy (1)
June 20, 2005
- Special Contribution
May 16, 2005
- Japan's Most Admired Pharma Companies P. Reed Maurer President, NPP
April 18, 2005
- PRTM Shows Results of Investigational Drug Survey
March 14, 2005
- <Special Comtribution>
March 7, 2005
- <Special Comtribution>
March 7, 2005
- JPMA Update (12)
November 22, 2004
- JPMA Pudate(11)
November 15, 2004
- JPMA Update (10)
November 8, 2004
ページ
Focus: How to Get the Talent You Need in a Tough MarketThe Japanese life sciences sector presents a challenging landscape for global companies. To succeed, you must move beyond reactive hiring and adopt a truly strategic talent acquisition model. Our…
